In This Section

Newsroom

  • Riyaz Bashir, MD, FACC, in an operating room, holding an endovascular catheter

    Endovascular Catheter Developed at the Lewis Katz School of Medicine at Temple University Shows Unprecedented Ability to Treat Pulmonary Artery Obstruction

    A device known as the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.) significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism, researchers from the Lewis Katz School of Medicine at Temple University announced in a Late-Breaking Innovation session at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) conference in Boston.

  • Riyaz Bashir, MD, FACC, in an operating room, holding an endovascular catheter

    Multiple Media Outlets Highlight Breakthrough News about the BASHIR™ Endovascular Catheter

    Researchers at the Lewis Katz School of Medicine at Temple University announced in a Late-Breaking Innovation Session at the 2022 Transcatheter Cardiovascular Therapeutics conference that the BASHIR™ Endovascular Catheter significantly reduces the size of blood clots lodged in pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism. The breakthrough is also described in a report published in the Journal of the American College of Cardiology: Cardiovascular Interventions. Riyaz Bashir, MD, FACC, Professor of Medicine at the Katz School of Medicine and Director of Vascular and Endovascular Medicine at Temple University Hospital, is the co-inventor of the catheter. Dr. Bashir conducted a video interview with Clinical Trial Results about the catheter and the RESCUE trial, a clinical study designed to evaluate the safety and efficacy of the catheter as a novel therapy for pulmonary embolism. The American College of Cardiology, Scienmag and the Science Times also highlighted the news. Parth Rali, MD, Associate Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine and Director of the Temple University Health System Pulmonary Embolism Response Team (PERT), is the local principal investigator on the RESCUE trial. Vladimir Lakhter, DO, Assistant Professor of Medicine at the Lewis Katz School of Medicine and an interventional cardiologist, is also involved in the RESCUE trial.

  • Daniel A. Salerno, MD, MS

    Dr. Daniel Salerno and Patient Share Diagnosis and Treatment for Mycobacterium Avium Complex in Philadelphia Inquirer’s ‘Medical Mystery’ Feature

    Daniel A. Salerno, MD, MS, Associate Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of Critical Care Services in the Respiratory Intensive Care Unit at Temple University Hospital, and a patient shared the story of her diagnosis and treatment for mycobacterium avium complex (MAC) in the Philadelphia Inquirer’s “Medical Mystery” feature.

  • Carolyn Y. Fang, PhD and Jean Lee, MD, FACP

    Dismantling Discrimination in Healthcare: Asian American and Pacific Islander Heritage Month Award Winners

    Nine individuals associated with the Lewis Katz School of Medicine and Temple University Health System have been honored with Health Equity Leadership and Social Justice Awards for their efforts to raise awareness of the discrimination faced by many Asian Americans and Pacific Islanders -- and for their work to dismantle the barriers to healthcare that result from it.

  • Jamie Garfield, MD

    Lewis Katz School of Medicine’s Efforts Featured in Philadelphia Inquirer Article about Standardized Patients in Medical Education

    A Philadelphia Inquirer article focused on how area medical schools, including the Lewis Katz School of Medicine at Temple University, are utilizing standardized patients in medical education. The Inquirer article highlighted a new grant that Temple received to develop an educational program to promote sensitive and equitable care for transgender and nonbinary people in Philadelphia. Jamie Garfield, MD, Professor of Thoracic Medicine and Surgery and Core Clinical Educator at the Katz School of Medicine and Director of Quality and Improvement and Patient Safety, Core Clinical Faculty, Internal Medicine Residency, at Temple University Hospital, is the principal investigator on the grant and spoke with the Inquirer. Denise Salerno, MD, FAAP, Associate Dean of Undergraduate Medical Education and Longitudinal Curricular Threads and Professor of Clinical Pediatrics at the Katz School of Medicine, and David A. Wald, DO, FACOEP, Interim Assistant Dean of Phase 3 and Assistant Dean of Clinical Simulation and Professor of Emergency Medicine at the Katz School of Medicine, were also interviewed.

  • Leah Croll, MD

    Dr. Leah Croll Provides Perspective to ABC News and the Philadelphia Inquirer on the Recovery Process from a Stroke

    Leah Croll, MD, Assistant Professor of Clinical Neurology at the Lewis Katz School of Medicine at Temple University, provided perspective to ABC News on the recovery process from a stroke after Pennsylvania U.S. Senate candidate John Fetterman sustained a stroke in May. Dr. Croll discussed cognitive assessments and reiterated that each patient is different and only they and their physicians can judge their fitness for work.

  • ACCME Accredited with Commendation

    Accredited with Commendation: Continuing Medical Education at the Lewis Katz School of Medicine

    A distinction at the pinnacle of industry standards has been awarded to the Albert J. Finestone, MD Office for Continuing Medical Education at the Lewis Katz School of Medicine: Accreditation with Commendation. 

  • Tomasz Skorski, MD, PhD, DSc and Neil Johnson, PhD

    Leading Researchers on DNA Repair, Personalized Medicine to Speak at October Temple Symposium

    Temple researchers will bring together world-leading scientists and clinicians to discuss one of medicine’s most vital quests: understanding the role of genetic changes in the development of cancer and other diseases – and using that knowledge to develop more effective treatments.  

Pages